Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biom’Up Raises EUR 6.8 Million

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
These funds will be used to accelerate the company’s commercial development and finance clinical studies into two future innovative ranges of medical implants.

Biom’Up has announced that it has raised EUR 6.8 million in new funds from existing shareholders and acquired three new investors: the InnoBio fund, managed by CDC Entreprises under the ‘FSI France Investissement’ program, Viveris Management and OTC Asset Management.

As a result of the new funding, the new partners join the investors already associated with Biom’Up: Merieux Developpement, SHAM, Sofimac Partners, Aquasourca and L’Ameliane, alongside founders and managers Sylvain Picot (CEO) and Patricia Forest (deputy CEO and scientific director).

“Previous fundraising has enabled us to recruit the first members of the sales force and finance the R&D stages for two new product ranges,” explains Sylvain Picot, CEO of Biom’Up.

Picot continued, “The new funds will be used to strengthen the sales team significantly in order to accelerate the roll out of domestic and export sales.”

Biom’Up plans to recruit several additional sales representatives in the coming year for France. On the export side, the company will focus its sales efforts on the US and Europe.

At the same time, Biom’Up will finance a phase III clinical trial in Europe and the US for a new innovative range of products targeted at the major markets of surgery and regenerative medicine.

In addition, Biom’Up has implemented a development strategy in the US, filing initial applications (510k) with the Food and Drug Administration (FDA) and setting up a multi-disciplinary scientific advisory board consisting of recognized opinion leaders in France and the US.

“We are very pleased to support Biom’Up. We are impressed by the positioning and the quality of the products developed by the company,” says Thibaut Roulon, investment director at CDC Entreprises.

Roulon continued, “The products developed by Biom’Up offer a response to identified medical needs across major markets and meet the expectations of surgeons.”

Since 2009, Biom’Up has been selling its ranges of proprietary products: COVA™, a membrane for the prevention of adhesions and controlled healing, in Europe and the US and MATRI™ BONE, a bone regeneration matrix, in Europe. These ranges meet a strong demand in markets evaluated at several million euros.

COVA™ and MATRI™ BONE have proved to be clinically effective and add value for various types of surgery. These two initial ranges provide a new response to the requirements of surgery and regenerative medicine: for example, COVA™ makes corrective surgery more secure in cardiac paediatric cases.

Its handling and innovative mechanical properties also make it ideal for use in laparoscopy, delivering excellent results, especially in the prevention of adhesions in gastro-intestinal and gynecological surgery.

“The arrival of these new partners, which are highly committed to the life sciences sector, will enable us to cement our development in the European markets and penetrate the US market,” said Sylvain Picot. “This is also reflected in the strengthening of governance bodies within the company, enabling it to draw on experience and shareholder networks.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!